论文部分内容阅读
目的:探讨胸腔置入中心静脉导管(以下简称导管)治疗结核性胸腔积液(以下简称胸水)的价值。方法:278例患者(无包裹性)按数字随机法分为治疗组和对照组,比较两组疗效、并发症及医疗费用。结果:治疗组胸水吸收快(1.6±0.8)d vs(11.4±6.3)d,住院时间短(7.4±2.3)d vs(15.5±6.4)d,医疗费用低(1417.9±341.8)元vs(2390.9±606.8)元,并发症少,两组差异具有统计学意义(P<0.05)。结论:胸腔内置入导管并注入尿激酶治疗结核性胸水,简便安全,疗效确切。
Objective: To investigate the value of pleural placement of central venous catheter (hereinafter referred to as catheter) in the treatment of tuberculous pleural effusion (hereinafter referred to as pleural effusion). Methods: 278 patients (no package) were divided into treatment group and control group according to the number randomization. The curative effect, complications and medical expenses of the two groups were compared. Results: The pleural effusion in the treatment group was faster (1.6 ± 0.8) d vs (11.4 ± 6.3) d, shorter in hospital stay (7.4 ± 2.3) d vs (15.5 ± 6.4) d, lower in medical expenses (1417.9 ± 341.8) vs ± 606.8) yuan, fewer complications, the difference between the two groups was statistically significant (P <0.05). Conclusion: The intrathoracic catheterization and injection of urokinase in the treatment of tuberculous pleural effusion, simple and safe, the exact effect.